Skip to main content

Table 1 Patient Characteristics of the Freiburg Study Collective. Fédération Internationale de Gynécologie et d’Obstétrique (FIGO) staging based on Pecorelli et al. 1999 [31]

From: Biomarker-based early detection of epithelial ovarian cancer based on a five-protein signature in patient’s plasma – a prospective trial

 

Total

Benign

Malign

Number

43

25

18

Age Median ± IQR (Years)

53 ± 17

48 ± 20

59 ± 18

Histology

 Serous Cystadenoma

9

9

0

 Endometriosis Cyst

5

5

0

 Dermoid Cyst

6

6

0

 Ovarian Fibroma

2

2

0

 Other

3

3

0

 epithelial ovarian cancer

18

0

18

FIGO Stages

 FIGO I-II

4

0

4

 FIGO III-IV

14

0

14